ASX - By Stock
|
ADO |
Re:
2024 - The year of ADO
|
|
ChrisBarr
|
727 |
241K |
12 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
727
|
241K
|
12
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Company Update
|
|
ChrisBarr
|
324 |
113K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
324
|
113K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Company Update
|
|
ChrisBarr
|
324 |
113K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
324
|
113K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Company Update
|
|
ChrisBarr
|
324 |
113K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
324
|
113K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: FY22 Results Announcement
|
|
ChrisBarr
|
106 |
37K |
17 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
106
|
37K
|
17
|
|
ASX - By Stock
|
ADO |
Re:
Shooting the breeze on ADO
|
|
ChrisBarr
|
5.6K |
1.5M |
1 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
5.6K
|
1.5M
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Change of Director's Interest Notice
|
|
ChrisBarr
|
63 |
18K |
2 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
63
|
18K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: TGA Registration Update
|
|
ChrisBarr
|
2.4K |
730K |
9 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
2.4K
|
730K
|
9
|
|
ASX - By Stock
|
ADO |
Re:
Ann: TGA Registration Update
|
|
ChrisBarr
|
2.4K |
730K |
28 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
2.4K
|
730K
|
28
|
|
ASX - By Stock
|
ADO |
Re:
AnteoTech renews AnteoBind contract with Ellume
|
|
ChrisBarr
|
151 |
37K |
19 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
151
|
37K
|
19
|
|
ASX - By Stock
|
ADO |
Re:
Submitted to TGA tick, how long will the approval take?
|
|
ChrisBarr
|
118 |
36K |
1 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
118
|
36K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech Signs SE Asian Distribution Agreement for EuGeni
|
|
ChrisBarr
|
320 |
106K |
33 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
320
|
106K
|
33
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
ChrisBarr
|
3.3K |
1.1M |
4 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
4
|
|
ASX - By Stock
|
ADO |
Re:
Sona Saliva Test
|
|
ChrisBarr
|
47 |
16K |
2 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
47
|
16K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Sona Saliva Test
|
|
ChrisBarr
|
47 |
16K |
2 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
47
|
16K
|
2
|
|
ASX - By Stock
|
BPH |
Re:
Scomo Against PEP11 ABC Iinterview
|
|
ChrisBarr
|
373 |
134K |
18 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
373
|
134K
|
18
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Life Science Update
|
|
ChrisBarr
|
397 |
136K |
21 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
397
|
136K
|
21
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading February 19
|
|
ChrisBarr
|
388 |
70K |
0 |
19/02/21 |
19/02/21 |
ASX - Day Trading
|
388
|
70K
|
0
|
|
ASX - By Stock
|
ADO |
What will the free cash flow be used for?
|
|
ChrisBarr
|
1 |
652 |
0 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
1
|
652
|
0
|
|
ASX - By Stock
|
ADO |
Re:
The Revenue numbers could be staggering
|
|
ChrisBarr
|
68 |
22K |
25 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
68
|
22K
|
25
|
|
ASX - By Stock
|
ADO |
Re:
The Revenue numbers could be staggering
|
|
ChrisBarr
|
68 |
22K |
2 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
68
|
22K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
The Revenue numbers could be staggering
|
|
ChrisBarr
|
68 |
22K |
1 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
68
|
22K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
The Revenue numbers could be staggering
|
|
ChrisBarr
|
68 |
22K |
4 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
68
|
22K
|
4
|
|
ASX - By Stock
|
ADO |
The Revenue numbers could be staggering
|
|
ChrisBarr
|
68 |
22K |
20 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
68
|
22K
|
20
|
|
ASX - By Stock
|
RFX |
Re:
WTF
|
|
ChrisBarr
|
170 |
65K |
2 |
25/01/21 |
25/01/21 |
ASX - By Stock
|
170
|
65K
|
2
|
|
ASX - By Stock
|
FMG |
Re:
Ann: Dr Andrew Forrest Boyer Lecture
|
|
ChrisBarr
|
108 |
51K |
4 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
108
|
51K
|
4
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Up to $1.4m in Qld Grant for COVID-19 test development
|
|
ChrisBarr
|
142 |
43K |
4 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
142
|
43K
|
4
|
|
ASX - By Stock
|
ADO |
Re:
ADO Analysis
|
|
ChrisBarr
|
4.3K |
2.5M |
30 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
4.3K
|
2.5M
|
30
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech Developing Multiplex Test for COVID-19
|
|
ChrisBarr
|
768 |
194K |
12 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
768
|
194K
|
12
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Trading Halt
|
|
ChrisBarr
|
243 |
45K |
12 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
243
|
45K
|
12
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Appendix 2A
|
|
ChrisBarr
|
12 |
6.3K |
0 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
12
|
6.3K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Appendix 2A
|
|
ChrisBarr
|
12 |
6.3K |
7 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
12
|
6.3K
|
7
|
|
ASX - By Stock
|
SAS |
Re:
Ann: Entitlement Issue Prospectus
|
|
ChrisBarr
|
242 |
106K |
3 |
13/11/19 |
13/11/19 |
ASX - By Stock
|
242
|
106K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Shareholder Update
|
|
ChrisBarr
|
418 |
260K |
3 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
418
|
260K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Shareholder Update
|
|
ChrisBarr
|
418 |
260K |
9 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
418
|
260K
|
9
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Shareholder Update
|
|
ChrisBarr
|
418 |
260K |
12 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
418
|
260K
|
12
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Suspension from Official Quotation
|
|
ChrisBarr
|
619 |
332K |
2 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
619
|
332K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Suspension from Official Quotation
|
|
ChrisBarr
|
619 |
332K |
0 |
02/10/19 |
02/10/19 |
ASX - By Stock
|
619
|
332K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Suspension from Official Quotation
|
|
ChrisBarr
|
619 |
332K |
8 |
02/10/19 |
02/10/19 |
ASX - By Stock
|
619
|
332K
|
8
|
|
ASX - By Stock
|
KDR |
Re:
Voice your opinion about this offer
|
|
ChrisBarr
|
199 |
111K |
0 |
08/05/19 |
08/05/19 |
ASX - By Stock
|
199
|
111K
|
0
|
|